Martin Iain Bahl

15PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyMicrobial ecologyFood properties (incl. characteristics and health benefits)Medical biochemistry - amino acids and metabolites
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 30, 2026
Method of oral delivery affects vitamin C-mediated alleviation of colitis in a mouse model.

Pi Westi Bondegaard, Katja Ann Kristensen, Khorshid Kamguyan

|Jan 12, 2026
Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization.

Pernille Neve Myers, Rasmus Kaae Dehli, Axel Mie

|Jan 08, 2025
Oral amoxicillin treatment disrupts the gut microbiome and metabolome without interfering with luminal redox potential in the intestine of Wistar Han rats.

Sandra Bermúdez-Sánchez, Martin Iain Bahl, Egon Bech Hansen

|Oct 20, 2023
Delivery of E. coli Nissle to the mouse gut by mucoadhesive microcontainers does not improve its competitive ability against strains linked to ulcerative colitis.

Pi Westi Bondegaard, Anders Meyer Torp, Priscila Guerra

|May 24, 2023
Human milk oligosaccharides induce acute yet reversible compositional changes in the gut microbiota of conventional mice linked to a reduction of butyrate levels.

Andrea Qvortrup Holst, Harshitha Jois, Martin Frederik Laursen

|Apr 07, 2023
An engineered Escherichia coli Nissle 1917 increase the production of indole lactic acid in the gut.

Chrysoula Dimopoulou, Mareike Bongers, Mikael Pedersen

Pageof 3

Frequent Collaborators

14 joint publications

Tine Rask Licht

8 joint publications

Martin Frederik Laursen

4 joint publications

Janne Marie Moll

4 joint publications

Susanne Brix